top of page

Latest News

Interview

CBC Radio One

Feb 15, 2024

Up to Speed with Faith Fundal

Up to Speed with Faith Fundal
Featuring:

Cynthia Mitchell

Opinion

The Globe and Mail

Feb 3, 2024

Our clinical trials system is failing Canadians with Cancer

Our clinical trials system is failing Canadians with Cancer
Featuring:

Rebecca Auer

Advocacy

La Presse

Sep 28, 2023

Inquiétudes pour l’accès aux médicaments non approuvés (Concerns about access to unapproved drugs)

Inquiétudes pour l’accès aux médicaments non approuvés (Concerns about access to unapproved drugs)
Featuring:

Julie Carignan

Advocacy

Macleans Canada

Aug 3, 2023

Stories from the frontlines of the fight for access to innovative therapies

Stories from the frontlines of the fight for access to innovative therapies
Featuring:

Julie Carignan

Press Release

The Ottawa Hospital Research Institute

Apr 13, 2023

Bringing cellular immunotherapy to solid tumours: made-in-Canada approach

Bringing cellular immunotherapy to solid tumours: made-in-Canada approach
Featuring:

The C3

  • Facebook
  • Instagram
  • LinkedIn
  • Youtube
  • Twitter
logoImage.png
leaf-cihr-colour-en_edited.png

The Canadian Cholangiocarcinoma Collaborative (C3) is supported by a Canadian Cancer Society Breakthrough Team Grant in partnership with the Canadian Institutes of Health Research. The granting funds for C3 are managed by The Ottawa Hospital Research Institute, which serves as the lead institute for all collaborative operations.

© 2025 www.cholangio.ca. All rights reserved.

bottom of page